Healthcare Industry News: Stereotactic
News Release - November 19, 2013
South Korea’s Yonsei University Health System orders four Elekta radiation therapy systemsSTOCKHOLM, Sweden--(Healthcare Sales & Marketing Network)--Yonsei University Health System (YUHS) has reinforced its commitment to Elekta’s radiation therapy systems with the recent order of four additional high-end Elekta linear accelerators. The four linear accelerators, representing an order value of approximately USD 10 million, were booked in the second quarter of fiscal year 2013/14.
“These systems provide YUHS the flexibility to treat the full spectrum of conventional radiotherapy techniques with advanced Stereotactic precision,” says Ki-Chang Keum, MD, Chief Professor and Chairman of the Radiation Oncology Department at YUHS.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on November 19, 2013.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO: EKTAB. Website: www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.